Core Points - PROACTIS SA has postponed the publication of its results and Annual Financial Report for the year ending January 31, 2025, which was originally scheduled for May 30, 2025 [1] - The delay is due to issues in finalizing the audit by statutory auditors of PROACTIS HOLDING LIMITED and agreeing on matters related to goodwill impairment and going concern [2] - PROACTIS SA and PROACTIS HOLDING LIMITED are taking necessary steps to complete the audits as quickly as possible and will announce new publication dates soon [3] Company Overview - PROACTIS SA provides business spend management and collaborative business process automation solutions, integrating with various ERP and procurement systems [4] - The company operates in multiple countries, including France, Germany, the USA, and Manila [4] - PROACTIS SA is listed in Compartment C on the Euronext Paris Eurolist [5]

Group 1: Share Buyback Details - Sanoma Corporation executed a share buyback on 30 May 2025, acquiring 4,797 shares at an average price of EUR 9.4988 per share, with a total cost of EUR 45,565.74 [1] - The highest price per share during the buyback was EUR 9.5000, while the lowest was EUR 9.4800 [1] - Following this transaction, the company holds a total of 782,988 of its own shares [2] Group 2: Company Overview - Sanoma is described as an innovative and agile learning and media company, impacting millions daily and committed to sustainability [2] - The company offers a range of learning products and services, including printed and digital content for various educational levels, aiming for business growth [3] - In 2024, Sanoma reported net sales of approximately EUR 1.3 billion and an operational EBIT margin excluding PPA of 13.4% [4]

Company Overview - Society Pass Inc. is a data-driven loyalty, fintech, and e-commerce ecosystem founded in 2018, operating in fast-growing Southeast Asian markets including Vietnam, Indonesia, Philippines, Singapore, and Thailand, which collectively represent over 80% of the SEA population [3] - The company operates six interconnected verticals: loyalty, digital media, travel, telecoms, lifestyle, and food & beverage, connecting millions of registered consumers and hundreds of thousands of merchants across various product and service categories [3][5] - Society Pass went public in November 2021, trading on Nasdaq under the ticker SOPA [4] Business Model and Growth Strategy - Society Pass focuses on acquiring fast-growing e-commerce companies to expand its user base and integrate these businesses through its Society Pass fintech platform and universal loyalty points system, Society Points, which is in beta testing and expected to launch broadly in early 2023 [5] - The company has over 3.3 million registered consumers and more than 650,000 registered merchants and brands, supported by proprietary IT architecture developed over two years [5][6] - Society Pass operates several key subsidiaries, including Thoughtful Media Group, NusaTrip, VLeisure, Gorilla Global, Leflair.com, Pushkart.ph, and NextGen Retail, enhancing its service offerings across various sectors [6] Future Plans and Market Potential - In October 2023, Society Pass announced plans to spin off two of its businesses, Thoughtful Media Group Inc. and NusaTrip Inc., through IPOs in 2024, which are expected to create significant value for shareholders and act as key growth catalysts in 2025 [7] - The company is currently trading at a market capitalization of approximately $7 million, with an equivalent amount in cash, indicating that its shares and business are significantly undervalued [7] - Ascendiant Capital Markets has raised the 12-month price target for Society Pass to $15 from $14, reflecting a positive outlook based on a net present value analysis, which suggests substantial upside potential from the current share price [7]

Core Points - Brunswick Exploration Inc. closed a private placement for gross proceeds of C$3,500,000, including C$1,000,000 from the agents' option [1] - The Offering consisted of 12,980,769 LIFE Units sold at C$0.13 each and 12,083,333 Non-LIFE Units sold at C$0.15 each, totaling 25,064,102 Offered Securities [1][2][3] - The proceeds will be used for exploration activities in Québec and Greenland, as well as for general corporate purposes and working capital [8] Offering Details - Each LIFE Unit includes one common share and half a warrant, with the warrant allowing purchase of a share at C$0.20 until May 30, 2028 [2] - Each Non-LIFE Unit consists of one common share and one warrant, with the warrant allowing purchase of a share at C$0.25 until May 30, 2028 [3] - The Offering was facilitated by Red Cloud Securities Inc. and Canaccord Genuity Corp., who received a cash commission of C$181,515 and broker warrants [4] Insider Participation - Insiders participated in the Offering, receiving a total of 70,000 common shares, which is classified as a related party transaction [5] - The Offering is exempt from formal valuation and minority shareholder approval requirements as the value does not exceed 25% of the Corporation's market capitalization [5] Regulatory Compliance - The LIFE Units were offered under the listed issuer financing exemption, making them immediately tradeable in Canada [6] - The Non-LIFE Units were offered under accredited investor and minimum amount investment exemptions, subject to a four-month hold period [7] - Completion of the Offering is pending final approval from the TSX Venture Exchange [7] Company Overview - Brunswick Exploration is focused on grassroots exploration for lithium in Canada, a critical metal for global decarbonization and energy transition [10][11] - The company is advancing a significant lithium property portfolio in Canada and Greenland [11]

Company Launches Far-Reaching Bitcoin Treasury Strategy SARASOTA, Fla., May 30, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that it has closed its previously announced private placement offering (“the Offering”) with approximately 50 institutional investors. The Offering consisted of the sale of (i) ...

WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™. Tevogen.AI™ aims to integrate advanced machine learning and predictive modeling into Tevogen Bio’s proprietary ExacTcell™ technology to significantly enhance its target identification and pre-clinical processes, thereby strengthening the Company’s pipeline of innovative immunotherapies, a ...

EXL Code Harbor™ solution speeds code migration from SAS to Databricks with up to 80% reduction in manual effortNEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data and AI company, expanded its partnership with Databricks, the data and AI company, to deploy a GenAI-enabled SAS to Databricks Data Intelligence Platform migration solution. Leveraging EXL’s Code Harbor™ solution, the solution helps enterprises streamline their transition from SAS to Databricks to support enhanced cloud ...

Core Insights - Fortress Biotech's subsidiary Checkpoint Therapeutics has been acquired by Sun Pharmaceutical Industries for $4.10 per share in cash, with additional contingent value rights and royalties tied to future sales of UNLOXCYT™ [1][2] Financial Details - Fortress will receive approximately $28 million shortly after the closing of the transaction and is eligible for an additional contingent value right (CVR) of up to $4.8 million, plus a 2.5% royalty on future net sales of UNLOXCYT™ [1][2] - The acquisition deal was approved by Checkpoint's stockholders on May 28, 2025, and closed on May 30, 2025 [1][2] Product Information - UNLOXCYT™ (cosibelimab-ipdl) is the first and only FDA-approved PD-L1 blocking antibody for advanced cutaneous squamous cell carcinoma, receiving FDA approval in December 2024 [3] Company Strategy - Fortress Biotech focuses on acquiring and advancing biopharmaceutical assets to enhance long-term shareholder value through product revenue, equity holdings, and dividend and royalty revenue [4] - The company aims to strengthen its balance sheet through opportunistic transactions and is actively evaluating business development opportunities [2][4]

UAB “Atsinaujinančios energetikos investicijos” (the Company) publishes its unaudited interim condensed consolidated financial statements for the 3-month period of 2025. Financial results As at 31 March 2025, the Company’s total assets were EUR 189 711 thousand, total equity was EUR 98 345 thousand, and total liabilities were EUR 91 366 thousand. As at 31 March 2025, the Company’s investment assets at fair value through profit or loss were EUR 167 392 thousand, which compared to 31 December 2024, increase ...

HONG KONG, May 30, 2025 (GLOBE NEWSWIRE) -- Pitanium Limited (“Pitanium” or the “Company”), a company that retails its proprietary brand focusing on beauty and personal care products, announced today that it priced its initial public offering of 1,750,000 Class A ordinary shares (the “Class A Ordinary Shares”) at $4.00 per Class A Ordinary Share (the “Offering”). Cathay Securities, Inc. acted as the sole underwriter to the Offering (the “Underwriter”). The Company granted the Underwriter a 45-day option to ...